norfloxacin tablets 400mg manufacturers

Nofloxacin 400 mg Tablets An Overview of Manufacturers

Nofloxacin is a fluoroquinolone antibiotic that is primarily used for the treatment of various bacterial infections, particularly those affecting the urinary tract and the gastrointestinal system. Available in a 400 mg tablet dosage form, Nofloxacin has gained popularity due to its efficacy and convenience of use. Given its significance in medical treatment, understanding the landscape of manufacturers producing Nofloxacin 400 mg tablets is essential for healthcare professionals and patients alike.

The Role of Nofloxacin in Medicine

Nofloxacin works by inhibiting bacterial DNA synthesis, a crucial process for bacterial growth and replication. Its broad-spectrum activity makes it effective against a wide range of gram-negative and some gram-positive bacteria. Common indications for Nofloxacin include urinary tract infections (UTIs), prostatitis, and certain types of gastroenteritis. The introduction of Nofloxacin in the pharmaceutical market has provided an important alternative for treating these infections, especially in cases where other antibiotics may not be effective due to bacterial resistance.

Key Manufacturers of Nofloxacin 400 mg Tablets

1. Bristol-Myers Squibb As one of the pioneering companies in pharmaceutical innovation, Bristol-Myers Squibb was one of the first manufacturers to produce Nofloxacin. Their reputation is built on quality and stringent manufacturing standards, ensuring that their Nofloxacin tablets are reliable and effective.

2. Cipla Ltd Cipla is a major player in the global pharmaceutical industry, known for its commitment to affordable healthcare. The company offers Nofloxacin 400 mg tablets, ensuring high-quality production while making the medication accessible to patients worldwide. Cipla’s extensive distribution network enhances the availability of its products, including Nofloxacin.

3. Mylan Now part of Viatris, Mylan has diversified its portfolio to include various generic and branded medications, including Nofloxacin 400 mg tablets. Mylan is known for its focus on producing high-quality generics, allowing more patients access to necessary treatments at lower costs.

4. Teva Pharmaceuticals As one of the largest generic pharmaceutical companies globally, Teva produces Nofloxacin 400 mg tablets with a focus on quality and consistency. Teva’s commitment to research and development has also led to the continuous improvement of its pharmaceutical products.

5. Zydus Cadila This Indian multinational pharmaceutical company is known for innovating and manufacturing a diverse range of pharmaceutical products. Zydus Cadila has established itself as a reputable manufacturer of Nofloxacin 400 mg tablets, ensuring compliance with international quality standards.

Importance of Quality Control

The manufacture of Nofloxacin 400 mg tablets is subject to rigorous quality control measures. Compliance with the Good Manufacturing Practices (GMP) regulations set by governing bodies such as the U.S. Food and Drug Administration (FDA) and the World Health Organization (WHO) is crucial. These standards ensure that every batch of medication produced contains the correct dosage, purity, and is free from contaminants. Patients depend on the efficacy of these tablets, making quality control a critical aspect of pharmaceutical manufacturing.

Conclusion

Nofloxacin 400 mg tablets represent a vital option in the treatment of bacterial infections. With multiple manufacturers dedicated to producing this antibiotic, the landscape is diverse and competitive, contributing to better availability and potentially lower prices for consumers. Whether prescribed for a urinary tract infection or another bacterial condition, patients can rest assured that the Nofloxacin they receive comes from a manufacturer committed to quality and efficacy. As antibiotic resistance becomes an increasing concern in healthcare, the importance of reliable medications like Nofloxacin cannot be overstated. Understanding the manufacturers and their roles in providing this critical drug is essential for prescribers and patients navigating their treatment options.